NeuroNascent
NeuroNascent, Inc. - Neurogenesis, Neurodegeneration, Alzheimer's Disease, Stroke, Hibernation, Maryland Biotech, small molecule therapeutics, Neuron.
Launch date
Employees
Market cap
-
Enterprise valuation
$5—7m (Dealroom.co estimates Mar 2015.)
Clarksville Tennessee (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$50.0k | Early VC | ||
| N/A | $1.2m | Early VC | |
* | N/A | Grant | |
| Total Funding | $1.3m | ||
Related Content
Recent News about NeuroNascent
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.